class='kwd-title'>Keywords: Plasmodium falciparu'/> Imidazopyridazines as potent inhibitors of Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK1): Preparation and evaluation of pyrazole linked analogues
首页> 美国卫生研究院文献>Elsevier Sponsored Documents >Imidazopyridazines as potent inhibitors of Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK1): Preparation and evaluation of pyrazole linked analogues
【2h】

Imidazopyridazines as potent inhibitors of Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK1): Preparation and evaluation of pyrazole linked analogues

机译:咪唑并哒嗪作为恶性疟原虫钙依赖性蛋白激酶1(PfCDPK1)的有效抑制剂:吡唑连接类似物的制备和评价

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

class="kwd-title">Keywords: Plasmodium falciparum, Calcium-dependent protein kinase 1, Malaria, Imidazopyridazine, SAR class="head no_bottom_margin" id="idm140316911578288title">AbstractThe structural diversity and SAR in a series of imidazopyridazine inhibitors of Plasmodium falciparum calcium dependent protein kinase 1 (PfCDPK1) has been explored and extended. The opportunity to further improve key ADME parameters by means of lowering log D was identified, and this was achieved by replacement of a six-membered (hetero)aromatic linker with a pyrazole. A short SAR study has delivered key examples with useful in vitro activity and ADME profiles, good selectivity against a human kinase panel and improved levels of lipophilic ligand efficiency. These new analogues thus provide a credible additional route to further development of the series.
机译:<!-fig ft0-> <!-fig @ position =“ anchor” mode =文章f4-> <!-fig mode =“ anchred” f5-> <!-fig / graphic | fig / alternatives / graphic mode =“ anchored” m1-> class =“ kwd-title”>关键字:恶性疟原虫,钙依赖性蛋白激酶1,疟疾,咪唑并哒嗪,SAR class =“ head no_bottom_margin“ id =” idm140316911578288title“>摘要已探索并扩展了恶性疟原虫钙依赖性蛋白激酶1(PfCDPK1)的一系列咪唑并哒嗪抑制剂的结构多样性和SAR。确定了通过降低log D进一步改善ADME关键参数的机会,这是通过用吡唑取代六元(杂)芳族连接基实现的。简短的SAR研究提供了关键的例子,这些例子具有有用的体外活性和ADME谱,对人激酶的良好选择性以及亲脂性配体效率的提高。因此,这些新的类似物为进一步开发该系列产品提供了可靠的额外途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号